a public good project by the
Synthesis
Company
of California

© 2026

Robert K. Hills | doi.page

0 works0 citations0 h-index

Robert K. Hills

University of Oxford(GB)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Retinoids in leukemia and cellular processes, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment

Most-Cited Works

→ Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials(2010)1,943 cited
→ Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party(2018)1,009 cited
→ Association between premature mortality and hypopituitarism(2001)1,009 cited
→ Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial(2004)896 cited
→ Assessment of Minimal Residual Disease in Standard-Risk AML(2016)822 cited
→ Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease(2012)756 cited

→ The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia(2007)

740 cited

→ Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials(2014)681 cited

→ Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial(2010)649 cited

→ A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment(2007)616 cited